Joint Procurement Office for Medicines: The 11th batch of collective procurement increases the opportunity for "non-shortlisted companies to make a comeback".

On September 20th, the National Drug Centralized Procurement Office announced the 11th batch of national organized drug centralized procurement documents. Regarding the resurrection mechanism for the 11th batch of centralized procurement, the person in charge of the Drug Joint Procurement Office pointed out that in order to guide more enterprises to be selected at suitable prices, this round of procurement has added the opportunity for "non-selected companies to be resurrected" on the basis of the past "selected for final negotiation".